Clinical Research Directory
Browse clinical research sites, groups, and studies.
Body Weight Changes After Switching to Lurasidone for Antipsychotic-induced Weight Gain in Bipolar Disorder: a Multicenter Retrospective Study of Selected Follow-up Cohort
Sponsor: Dong-Wook Kim
Summary
Study Objective: To evaluate the treatment effectiveness and safety by analyzing prescription patterns in a routine clinical practice setting and observing changes in clinical indicators (weight, BMI, HAM-D, CGI-S, CGI-I) among patients prescribed Lurasidone for the treatment of bipolar disorder. Study Design: Retrospective, Multi-center, Investigator-Initiated Observational Study.
Official title: A Retrospective Observational Study on Weight Change, Effectiveness, and Safety Following Switching to Lurasidone in Korean Patients With Bipolar Disorder Under Routine Clinical Practice
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
OBSERVATIONAL
Enrollment
155
Start Date
2024-09-09
Completion Date
2025-12-31
Last Updated
2026-09-22
Healthy Volunteers
No
Conditions
Interventions
Lurasidone
Lurasidone Hydrochloride 20mg/40mg/60mg/80mg/120mg, with patients followed up for 16 weeks after switching to Lurasidone Hydrochloride.
Locations (1)
Garam Mental Health Clinic
Seoul, South Korea